GPER1 and breast carcinoma: In breast cancer cells, GPER1 actions have been found to stimulate key regulators of the evolutionarily conserved Hippo pathway that involves the yes-associated protein 1 (YAP) and transcriptional coactivator with a PDZ-binding domain (TAZ), which are homologous transcription coactivators (40, 42).